Wednesday, January 15, 2020 4:20:39 PM
"The Company has finalized and executed a definitive agreement with Symtomax, a leading licensed cannabis cultivation company with the largest outdoor grow facilities in Europe. Symtomax has a number of agreements in place with European government health ministries to manufacture and distribute cannabidiol products through their health systems. Pending finalization of regulatory approvals, we expect this to start yielding revenue in the form of royalty payments for Greater Cannabis in year one of commercialization based on current timing projections. Further opportunities in Africa are being explored in parallel."
To me year one starts the day oraltabs.com goes live and the first product is sold. IMO they most likely have already received some royalty payments if production has already started.
"The company has been exploring options for large scale manufacturing. Our current manufacturing capabilities are limited to less than 10,000 units per month through our small-scale manufacturing facility and R&D lab in New Jersey. We have successfully identified and aligned ourselves with two contract manufacturing organizations (CMOs). These two companies have decades of experience with manufacturing our dosage forms for Rx products, and our team has worked with them in the past. They offer us cGMP manufacturing capabilities with the ability to produce millions of units per month. This is a critical milestone for the Company to be able to achieve market penetration through our partners’ distribution channels. For partner companies needing a THC product, we have aligned ourselves with two companies that manufacture the machinery required to produce our delivery system in our partners’ facilities as opposed to in our CMOs facilities. We believe with these two options available we can now advance our commercialization strategy and begin to take products out of the lab and into the hands of consumers.'
https://www.otcmarkets.com/stock/GCAN/news/The-Greater-Cannabis-Company-Provides-Corporate-Update-to-Shareholders?id=240905
Pretty sure they are talking Symtomax here.
CBD retail is dead. Find something better. JMHO.
Recent GCAN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 02:43:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/12/2024 10:03:45 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2024 12:58:24 PM
- Form PRER14C - Information statements • Edgar (US Regulatory) • 02/26/2024 09:09:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 08:37:40 PM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM